AXA Framlington Biotech GBP Z Acc (FUND:B784NS1) - Overview

Fund Report

AXA Framlington Biotech Fund GBP Z Acc

Key Stats
Morningstar® CategorySector Equity Biotechnology
Manager NameLinden Thomson
Inception Date16/04/2012
NAV 02/12/2016GBX 282.00
Day Change-1.36%
12 Month Yield0.00%
ISINGB00B784NS11
SEDOLB784NS1
Dividend FrequencySemi-Annually
Net Assets (mil) 31/10/2016519.62 GBP
Wrapper AvailabilityAll
Our Minimum Initial Investment1.00 Share
Pricing FrequencyDaily
Dealing Cut off Time11:00:00
Regular InvestmentYes
Actual Initial Charge0.00%
Exit Charge-
Custody ChargeYes
Fund Ongoing Charge0.83%
AMC0.75%
Fund Rebate-

Morningstar Rating™

4 Stars

Benchmarks

Fund Benchmark

NASDAQ Biotechnology TR USD

Morningstar® Benchmark

MSCI World/Biotechnology NR USD

Growth Of 10,000 (GBP) 30/11/2016

How has this security performed
20122013201420152016
Fund24.8965.2446.6812.29-2.49
Category21.0355.0438.5413.41-0.34
Benchmark37.6964.6138.9313.904.31
  • Fund: AXA Framlington Biotech Fund GBP Z Acc
  • Category: Sector Equity Biotechnology
  • Benchmark: MSCI World/Biotechnology NR USD
Trailing Returns % (GBP) 02/12/2016
FundCatBmark
YTD-7.57-4.942.12
3 Years Annualised15.1915.3616.95
5 Years Annualised26.5324.8731.12
10 Years Annualised15.7516.0719.28

Morningstar SRRI

Lower Risk
Higher Risk
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Potentially Lower ReturnsPotentially Higher Returns
Source: Morningstar

Investment Objective

The fund seeks to provide long-term capital appreciation by investing principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.

Portfolio Profile31/10/2016

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Top Holdings
NameSector%
IncreaseDecreaseNew since last portfolio
Gilead Sciences Inc Healthcare9.85
DecreaseBiogen Inc Healthcare9.05
IncreaseCelgene Corp Healthcare8.70
Alexion Pharmaceuticals Inc Healthcare7.75
Vertex Pharmaceuticals Inc Healthcare5.31
Asset Allocation %
LongShortNet
Stocks98.620.0098.62
Bonds0.000.000.00
Cash1.810.910.90
Other0.480.000.48
Top Stock Regions
Region%
United States87.71
Europe - ex Euro5.30
Eurozone4.79
United Kingdom1.80
Canada0.39
Top Stock Sectors
Stock Sector%
Healthcare100.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.